本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Tyra Biosciences, Inc.

30.63
-0.1700-0.55%
盤後30.750.1200+0.39%19:59 EDT
成交量:64.63萬
成交額:1,975.57萬
市值:18.22億
市盈率:-14.07
高:31.08
開:31.08
低:30.02
收:30.80
52周最高:40.65
52周最低:9.96
股本:5,948.52萬
流通股本:3,088.31萬
量比:1.45
換手率:2.09%
股息:- -
股息率:- -
每股收益(TTM):-2.1777
每股收益(LYR):-2.0125
淨資產收益率:-36.87%
總資產收益率:-23.64%
市淨率:4.70
市盈率(LYR):-15.22

資料載入中...

2026/06/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/03

重要事件披露

Form 8-K - Current report
2026/06/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/13

重要事件披露

Form 8-K - Current report
2026/05/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/12

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/24

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/17

重要事件披露

Form 8-K - Current report
2026/04/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/02

重要事件披露

Form 8-K - Current report
2026/03/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/04

重要事件披露

Form 8-K - Current report
2026/03/02

重要事件披露

Form 8-K - Current report